Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dombernowsky

Showing results (171-180 of 211) with videos related to

Pageof 22
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
Metastatic spinal cord compression secondary to lung cancerF Bach, N Agerlin, J B Sørensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Second-line treatment of small-cell lung cancer with the camptothecin-derivative GI147211: a study of the EORTC Early Clinical Studies Group (ECSG)C Sessa, J Wanders, M Roelvink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: a prospective randomised trial of 280 consecutive patientsF R Hirsch, K Osterlind, N Jeppesen, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1987
Bone metastases in primary operable breast cancer. The role of a yearly scintigraphyH S Thomsen, D Rasmussen, O Munck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative GroupA Ardizzoni, H Hansen, P Dombernowsky, et al.
Ugeskrift for Laeger|April 2, 1990
[Sarcoma treatment in Denmark]H T Mouridsen, P Dombernowsky, O M Jensen, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1987
VP-16 in advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and bone sarcoma groupP Dombernowsky, J Buesa, H M Pinedo, et al.
British Journal of Cancer|July 17, 1999
Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapyT Sigsgaard, J Herrstedt, L J Andersen, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1985
A randomized study of single agent vs combination chemotherapy in FIGO stages IIB, III and IV ovarian adenocarcinomaK Aabo, I Hald, S Hørbov, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Adjuvant treatment of postmenopausal patients with high risk primary breast cancer. Results from the Danish adjuvant trials DBCG 77 C and DBCG 82 CH T Mouridsen, C Rose, M Overgaard, et al.
Pageof 22

Showing results (171-180 of 211) with videos related to

Sort By:
Pageof 22
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1992
Metastatic spinal cord compression secondary to lung cancerF Bach, N Agerlin, J B Sørensen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2000
Second-line treatment of small-cell lung cancer with the camptothecin-derivative GI147211: a study of the EORTC Early Clinical Studies Group (ECSG)C Sessa, J Wanders, M Roelvink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2001
Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: a prospective randomised trial of 280 consecutive patientsF R Hirsch, K Osterlind, N Jeppesen, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1987
Bone metastases in primary operable breast cancer. The role of a yearly scintigraphyH S Thomsen, D Rasmussen, O Munck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1997
Topotecan, a new active drug in the second-line treatment of small-cell lung cancer: a phase II study in patients with refractory and sensitive disease. The European Organization for Research and Treatment of Cancer Early Clinical Studies Group and New Drug Development Office, and the Lung Cancer Cooperative GroupA Ardizzoni, H Hansen, P Dombernowsky, et al.
Ugeskrift for Laeger|April 2, 1990
[Sarcoma treatment in Denmark]H T Mouridsen, P Dombernowsky, O M Jensen, et al.
European Journal of Cancer & Clinical Oncology|May 1, 1987
VP-16 in advanced soft tissue sarcoma: a phase II study of the EORTC soft tissue and bone sarcoma groupP Dombernowsky, J Buesa, H M Pinedo, et al.
British Journal of Cancer|July 17, 1999
Granisetron compared with prednisolone plus metopimazine as anti-emetic prophylaxis during multiple cycles of moderately emetogenic chemotherapyT Sigsgaard, J Herrstedt, L J Andersen, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1985
A randomized study of single agent vs combination chemotherapy in FIGO stages IIB, III and IV ovarian adenocarcinomaK Aabo, I Hald, S Hørbov, et al.
Acta Oncologica (Stockholm, Sweden)|January 1, 1988
Adjuvant treatment of postmenopausal patients with high risk primary breast cancer. Results from the Danish adjuvant trials DBCG 77 C and DBCG 82 CH T Mouridsen, C Rose, M Overgaard, et al.
Pageof 22